EDESA BIOTECH, INC. Deferred Tax Assets, Tax Deferred Expense
EDESA BIOTECH, INC. (EDSA) had Deferred Tax Assets, Tax Deferred Expense of $585.00 thousand as of 2023-09-30, per its 10-K filed 2023-12-15.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2023-12-15
- 2023-09-30: Deferred Tax Assets, Tax Deferred Expense $585.00K.
- 2022-09-30: Deferred Tax Assets, Tax Deferred Expense $686.00K.
- 2021-09-30: Deferred Tax Assets, Tax Deferred Expense $628.00K.
- 2020-09-30: Deferred Tax Assets, Tax Deferred Expense $473.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense |
|---|---|
| 2023-09-30 | $585.00K 10-K · filed 2023-12-15 |
| 2022-09-30 | $686.00K 10-K · filed 2023-12-15 |
| 2021-09-30 | $628.00K 10-K · filed 2022-12-16 |
| 2020-09-30 | $473.00K 10-K · filed 2021-12-28 |
| 2019-09-30 | $517.00K 10-K · filed 2020-12-07 |
| 2018-12-31 | $26.00K 10-KT · filed 2019-12-12 |
| 2018-09-30 | $36.40K 10-K · filed 2018-11-30 |
| 2017-09-30 | $34.30K 10-K · filed 2018-11-30 |
| 2016-09-30 | $70.00K 10-K · filed 2017-12-01 |
| 2015-09-30 | $82.90K 10-K · filed 2017-12-01 |
| 2014-09-30 | $84.00K 10-K · filed 2016-12-14 |
| 2014-08-31 | $90.00K 10-K · filed 2016-12-14 |
| 2013-08-31 | $65.10K 10-K · filed 2015-12-14 |
| 2012-08-31 | $39.40K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |